Icon, which provides services to the pharmaceutical, biotechnology and medical device industries, has reported a net profit of $22.2m for the first quarter of this year, an increase of 6% from the same period last year. Net sales were marginally lower than a year earlier at $219m.
CEO Peter Gray described the performance as 'solid'. After lower booking levels and higher order cancellations last year, the company had forecast earlier this year that growth would re-emerge in the second half of 2010.
Mr Gray said that, although it remained cautious, the company believes the conditions for a return to growth were coming into place. He said Icon had booked $265m of business in the quarter.
